Norbert W. Bischofberger, EVP, R&D and CSO at GILEAD SCIENCES INC (GILD), sold 90,000 shares at $74.41 ($6.7M) on 2014-01-14, disclosed to the SEC on 2014-01-16.
Scheduled sale ($6.7M) by EVP, R&D and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.60 | 38,071 | $2.8M | 41.9% |
| 2 | $74.41 | 27,078 | $2.0M | 30.2% |
| 3 | $75.02 | 24,851 | $1.9M | 27.9% |
| Total | $74.24 avg | 90,000 | $6.7M | 100% |
| Filing → |
| KRON | BUY | 2023-11-17 | $2.7M | — | Filing → |
| KRON | BUY | 2022-05-19 | $3.4M | — | Filing → |
| KRON | BUY | 2021-12-08 | $347K | — | Filing → |